Clinical Trial Update: An Open-Label Study of 50 Mg Oral Testosterone Undecanoate (Kyztrex) in Menopausal Women with Low Testosterone and HSDD [Phase 2]

View source ↗

Summary

Open-label Phase 2 study evaluating 50 mg oral testosterone undecanoate (Kyztrex) in menopausal women with hypoactive sexual desire disorder; the trial status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoactive Sexual Desire Disorder

Drugs mentioned

• Kyztrex (testosterone undecanoate)

Snippet

Sponsor: San Diego Sexual Medicine | Conditions: Hypoactive Sexual Desire Disorder | Phase 2 | Status: NOT_YET_RECRUITING